InsidersTradesSigma
Discover the detailed record of transactions filed by Semigran Marc, Directeur Médical. Director active across 1 companies, notably Renovacor, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Marc Semigran is the Chief Medical Officer of Renovacor, Inc. In this role, he oversees the medical and clinical initiatives of the company, which focuses on developing innovative therapies. With a strong background in the medical field, he plays a crucial role in the research and development strategy of Renovacor, Inc.